Danielle Valletti, Assistant Editor

Datopotamab deruxtecan shows promise as a first-line treatment for metastatic triple-negative breast cancer, improving survival in nonimmunotherapy candidates.

Explore the evolving role of pharmacists in navigating FDA regulations and the impact of drug ads on patient care.

Discover how pharmacists play a crucial role in the OUD treatment process with buprenorphine, enhancing patient care and recovery outcomes.

FDA enhances oversight of drug ads using AI to ensure compliance, addressing risks and benefits in direct-to-consumer advertising.

Researchers uncover how apolipoprotein D (ApoD) increases influenza severity in older adults, highlighting the need for enhanced vaccines and new therapeutic strategies.

Pharmacists play a vital role in Breast Cancer Awareness Month, enhancing screening access and patient support through education and community engagement.

Explore the booming online pharmacy market for vitamins and supplements, and discover how pharmacists can guide patients in this digital landscape.

Umoja Biopharma's UB-VV111 gains FDA fast track designation, revolutionizing CAR T-cell therapy for relapsed lymphoma and leukemia patients.

Recent trials reveal fam-trastuzumab deruxtecan-nxki's potential to transform treatment for patients with high-risk HER2-positive breast cancer, enhancing survival rates significantly.

Pharmacists explore virtual solutions for opioid use disorder, enhancing treatment retention and accessibility while addressing economic impacts.

The FDA approves guselkumab, the first IL-23 inhibitor for pediatric psoriasis and psoriatic arthritis, enhancing treatment options for children.

Pharmacists play a crucial role in managing drug interactions and optimizing treatment with CDK4/6 inhibitors for HER2-positive breast cancer patients.

Pediatric flu cases surge, revealing alarming rates of encephalopathy.

Pharmacists enhance patient care by managing CDK4/6 inhibitors, addressing adverse effects and ensuring effective therapy selection in oncology.

Pharmacists enhance food safety by identifying foodborne illness symptoms, especially as FoodNet narrows its focus on E coli and Salmonella.

New intravenous formulation GTx-104 shows promise in improving brain health outcomes for patients with aSAH, offering safer treatment options for pharmacists.

Real-world data from nearly 1.5 million administrations of intranasal esketamine (Spravato) show that its safety profile—including risks of sedation, blood pressure changes, and dissociation—remains consistent with clinical trial findings.

Explore the impact of CDK4/6 inhibitors in HR+/HER2– breast cancer treatment and the essential role of oncology pharmacy practice.

New clinical trial results reveal that giredestrant combined with everolimus significantly enhances progression-free survival in patients with advanced ER-positive breast cancer.

Explore the evolving landscape of biological medicine, focusing on quality standards and innovations in cell and gene therapies for chronic diseases.

Fast-melt tablets may help improve adherence by offering patients a convenient alternative to traditional pills, especially for those experiencing pill fatigue or managing multiple medications.

Expert highlights how taste-masking, dose, and particle size influence patient adherence and the clinical performance of fast-dissolving delivery systems.

The BMJ study highlights that young children vaccinated against influenza in October experience the greatest protection, with lower infection rates than those vaccinated earlier.

Discover the benefits of fast melt tablets, designed for easy swallowing and quick disintegration, enhancing patient convenience and adherence.

West Coast states unite to enhance vaccine access and guidance for respiratory viruses, prioritizing public health and safety ahead of the 2025-2026 season.

Breast cancer survivors face a small but significant risk of developing secondary cancers, influenced by age, treatment, and lifestyle factors.

Crystal Hodge, PharmD, BCIDP, BCPS, discusses a 3-pronged approach—isolating, vaccinating, and educating—to help pharmacists manage respiratory virus season and routine immunizations like MMR.

New FDA regulations are intended to enhance transparency in prescription drug advertising, empowering pharmacists to educate patients on medication risks and benefits.

Pharmacists play a crucial role in managing myelofibrosis, enhancing patient education, adherence, and financial navigation for optimal care.